These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

511 related items for PubMed ID: 16702822

  • 1. Use of 24-h ambulatory blood pressure monitoring to assess blood pressure control: a comparison of olmesartan medoxomil and amlodipine besylate.
    Chrysant SG, Marbury TC, Silfani TN.
    Blood Press Monit; 2006 Jun; 11(3):135-41. PubMed ID: 16702822
    [Abstract] [Full Text] [Related]

  • 2. Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension.
    Chrysant SG, Marbury TC, Robinson TD.
    J Hum Hypertens; 2003 Jun; 17(6):425-32. PubMed ID: 12764406
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate.
    Kereiakes DJ, Neutel JM, Punzi HA, Xu J, Lipka LJ, Dubiel R.
    Am J Cardiovasc Drugs; 2007 Jun; 7(5):361-72. PubMed ID: 17953475
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study.
    Punzi HA.
    Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):12-21. PubMed ID: 24492985
    [Abstract] [Full Text] [Related]

  • 5. Amlodipine besylate/olmesartan medoximil fixed combination for the treatment of hypertension.
    Chrysant SG.
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):887-95. PubMed ID: 19673666
    [Abstract] [Full Text] [Related]

  • 6. Subgroup analyses of an efficacy and safety study of concomitant administration of amlodipine besylate and olmesartan medoxomil: evaluation by baseline hypertension stage and prior antihypertensive medication use.
    Oparil S, Lee J, Karki S, Melino M.
    J Cardiovasc Pharmacol; 2009 Nov; 54(5):427-36. PubMed ID: 19730391
    [Abstract] [Full Text] [Related]

  • 7. Combination therapy with olmesartan medoxomil and hydrochlorothiazide: secondary analysis of the proportion of patients achieving recommended blood pressure goals from a randomized, double-blind, factorial study.
    Chrysant SG, Chavanu KJ, Xu J.
    Am J Cardiovasc Drugs; 2009 Nov; 9(4):241-51. PubMed ID: 19655819
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of a structured treatment algorithm on blood pressure goal rates in both stage 1 and stage 2 hypertension.
    Neutel JM, Smith DH, Silfani TN, Lee Y, Weber MA.
    J Hum Hypertens; 2006 Apr; 20(4):255-62. PubMed ID: 16397514
    [Abstract] [Full Text] [Related]

  • 10. Effect of an olmesartan medoxomil-based treatment algorithm on systolic blood pressure in patients with stage 1 or 2 hypertension: a randomized, double-blind, placebo-controlled study.
    Kereiakes DJ, Maa JF, Shojaee A, Dubiel R.
    Am J Cardiovasc Drugs; 2010 Apr; 10(4):239-46. PubMed ID: 20653330
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre study.
    Volpe M, Brommer P, Haag U, Miele C.
    Clin Drug Investig; 2009 Apr; 29(1):11-25. PubMed ID: 19067471
    [Abstract] [Full Text] [Related]

  • 12. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [Abstract] [Full Text] [Related]

  • 13. Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil in achieving 24-hour blood pressure reductions and ambulatory blood pressure goals.
    Brunner HR, Arakawa K.
    Clin Drug Investig; 2006 Sep; 26(4):185-93. PubMed ID: 17163250
    [Abstract] [Full Text] [Related]

  • 14. The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study.
    Chrysant SG, Melino M, Karki S, Lee J, Heyrman R.
    Clin Ther; 2008 Apr; 30(4):587-604. PubMed ID: 18498909
    [Abstract] [Full Text] [Related]

  • 15. Comparison of olmesartan medoxomil versus amlodipine besylate on regression of ventricular and vascular hypertrophy.
    Rosendorff C, Dubiel R, Xu J, Chavanu KJ.
    Am J Cardiol; 2009 Aug 01; 104(3):359-65. PubMed ID: 19616668
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
    Neutel J, Shojaee A, Maa JF.
    Adv Ther; 2012 Jun 01; 29(6):508-23. PubMed ID: 22773358
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of amlodipine/olmesartan medoxomil ± hydrochlorothiazide in patients aged ≥ 65 or < 65 years with uncontrolled hypertension on prior monotherapy.
    Weir MR, Shojaee A, Maa JF.
    Postgrad Med; 2013 Mar 01; 125(2):124-34. PubMed ID: 23816778
    [Abstract] [Full Text] [Related]

  • 18. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K, Ogihara T, Saruta T, Kuramoto K, REZALT Study Group.
    Clin Ther; 2010 May 01; 32(5):861-81. PubMed ID: 20685495
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of olmesartan medoxomil plus amlodipine in age, gender and hypertension severity defined subgroups of hypertensive patients.
    Schmieder RE, Böhm M.
    J Hum Hypertens; 2011 Jun 01; 25(6):354-63. PubMed ID: 20686499
    [Abstract] [Full Text] [Related]

  • 20. Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan.
    Smith DH, Dubiel R, Jones M.
    Am J Cardiovasc Drugs; 2005 Jun 01; 5(1):41-50. PubMed ID: 15631537
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.